Biocon Biologics Recognized as Asia IP Elite for 2024 by IAM, Cementing Leadership in Intellectual Property Excellence

  • Posted by: Biocon Biologics

U.S. FDA Approves Biocon Biologics’ YESINTEK™, Bmab 1200 biosimilar to J&J’s Stelara® (Ustekinumab)

  • Posted by: Biocon Biologics

Biocon Celebrates 46th Founder’s Day with Anthem Launch, Walkathon, Leadership Talk and Experience Center Inauguration

  • Posted by: Biocon Biologics

Biocon Biologics Supports Diabetes Africa to Drive Progress in Embedding Specialist Nurses in Diabetes Care in Ethiopia

  • Posted by: Biocon Biologics

Biocon Academy Achieves 100% Placement within 2.5 hours for Quality Control Analytical Program

  • Posted by: Biocon Biologics

USFDA Classifies Biocon Biologics’ Biocon Park Site in Bengaluru, India as Voluntary Action Initiated (VAI)

  • Posted by: Biocon Biologics

Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr

  • Posted by: Biocon Biologics

Biocon Biologics’ Drug Substance Facility in Bengaluru Classified as Voluntary Action Indicated (VAI)

  • Posted by: Biocon Biologics

Biocon Continues to be Among Science Magazine’s Top 10 Global Employers List

  • Posted by: Biocon Biologics

Biocon Foundation Honored with ‘Doing Good for Bharat Awards 2024’ in ‘Healthcare Category’ for ‘eLAJ Smart Clinics’ by the CSR Box

  • Posted by: Biocon Biologics
Share
buy twitter followers - puff - Download video instagram - omegle